PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, featuring promising breakthroughs throughout numerous medical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, extra reputable choice for therapeutic use, notably in